Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Cash Flow Reinvestment Rate
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Reinvestment Rate of 0.50x as of December 2024, reinvesting CN¥57.97 Million (capex CN¥33.16 Million plus investments CN¥24.80 Million) from operating cash flow of CN¥116.38 Million. See Medprin Regenerative Medical Technologie free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Medprin Regenerative Medical Technologie.
Annual Cash Flow Reinvestment Rate for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Medprin Regenerative Medical Technologies Co. Ltd.. See 301033 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | CN¥57.97 Million | CN¥116.38 Million | CN¥33.16 Million | ▼ -34.5% |
| 2023 | 0.76x | CN¥81.93 Million | CN¥107.69 Million | CN¥40.09 Million | ▼ -76.2% |
| 2022 | 3.20x | CN¥154.51 Million | CN¥48.31 Million | CN¥135.96 Million | ▼ -54.5% |
| 2021 | 7.03x | CN¥467.64 Million | CN¥66.51 Million | CN¥152.71 Million | ▲ +55.4% |
| 2020 | 4.52x | CN¥153.41 Million | CN¥33.91 Million | CN¥61.65 Million | ▲ +9.7% |
| 2019 | 4.13x | CN¥129.03 Million | CN¥31.27 Million | CN¥36.71 Million | — |